HCA Healthcare Reports Second Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
HCA Holdings (HCA) PT Raised to $378 at RBC Capital
July 24, 2024 6:23 AM EDTRBC Capital analyst Frank Morgan raised the price target on HCA Holdings (NYSE: HCA) to $378.00 (from $329.00) while maintaining a Outperform rating.
The analyst comments "HCA rose to the challenge of high 2Q24 expectations with an impressive beat and raise, driven by continued demand... More
HCA Holdings (HCA) Tops Q2 EPS by 60c
July 23, 2024 7:36 AM EDTHCA Holdings (NYSE: HCA) reported Q2 EPS of $5.53, $0.60 better than the analyst estimate of $4.93. Revenue for the quarter came in at $17.49 billion versus the consensus estimate of $17.05 billion.
GUIDANCE:
HCA Holdings sees FY2024 EPS of $21.60-$22.80, versus the consensus of... More
